Advertisement

The Latest

Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.

Pain management is a specialty in flux. Not only are more chronic pain sufferers seeking out treatment, but the release of a recent Center for Disease Control report, which found more people die from prescription drug overdoses than heroin and…

Lawrence Dorr, MD, founder of the Dorr Arthritis Institute at Good Samaritan Hospital in Los Angeles, recently published a novel titled Die Once, Live Twice, detailing the history of medicine, according to a story from Authorlink.

Advertisement